Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03990558 · ClinicalTrials.gov registry record
Recovery of Consciousness Following Intracerebral Hemorrhage
A clinical trial of Intra Cerebral Hemorrhage, sponsored by Columbia University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT03990558 is a study of Intra Cerebral Hemorrhage that is actively recruiting participants, run by Columbia University. The registered enrollment target is 150 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03990558, a study of Intra Cerebral Hemorrhage, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objectives of the RECONFIG clinical study are to : 1. To identify the time to the first diagnosis of cognitive motor dissociation (CMD) in intracerebral hemorrhage (ICH) patients and to investigate whether these patients will clinically follow commands earlier after the hemorrhage. 2. To determine whether CMD independently predicts long term functional outcomes (6-month mRS scores) in ICH patients, and is associated with long term cognitive and quality of life outcomes. 3. To determine the EEG response to verbal commands of the motor imagery paradigm between patients with and without sensory aphasia. The overall goal is to determine predictors and the trajectory of neurological recovery.
Conditions Studied
Study Locations (2)
Florida
- University of Miami and Jackson Health System (UM/JHS) - Miami
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-06-15 |
| Est. Completion | 2026-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03990558
The ClinicalTrials.gov registry entry for NCT03990558 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intra Cerebral Hemorrhage appearing as the primary indexed condition, and to 0 interventions.
NCT03990558 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, New York.
Frequently Asked Questions
What is clinical trial NCT03990558 about?
NCT03990558 is a clinical study titled "Recovery of Consciousness Following Intracerebral Hemorrhage". The objectives of the RECONFIG clinical study are to : 1. To identify the time to the first diagnosis of cognitive motor dissociation (CMD) in intracerebral hemorrhage (ICH) patients and to investigate whether these patients will clinically follow commands earlier after the hemorrhage. 2. To determ...
What is the current status of trial NCT03990558?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2019-06-15. Estimated completion is 2026-03-31.
What conditions does trial NCT03990558 study?
This clinical trial studies the following conditions: Intra Cerebral Hemorrhage.
Who is sponsoring clinical trial NCT03990558?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03990558 being conducted?
This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intra Cerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.